Biovie Inc. (BIVIW) — S-1/A Filings
All S-1/A filings from Biovie Inc.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (4)
-
BIOVIE Amends S-1/A, Signals Continued Clinical Development Push
— Aug 4, 2025 Risk: high
BIOVIE INC. (BIVIW) filed an S-1/A on August 4, 2025, indicating an amendment to its registration statement. The company, operating in Pharmaceutical Preparatio -
BIOVIE Amends S-1/A, Signaling Capital Raise Efforts
— Jul 22, 2025 Risk: high
BIOVIE INC. (BIVIW) filed an S-1/A on July 22, 2025, indicating an amendment to its registration statement. The filing covers the period from July 1, 2024, to M -
BIOVIE Amends S-1/A, Signaling Capital Structure Adjustments
— Jul 11, 2025 Risk: medium
BIOVIE INC. (BIVIW) filed an S-1/A on July 11, 2025, indicating an amendment to its registration statement. The filing covers financial periods from July 1, 202 -
BioVie Inc. Files S-1/A Amendment
— Nov 27, 2024 Risk: medium
BioVie Inc. filed an S-1/A amendment on November 27, 2024, for its registration statement. The company, formerly known as NanoAntibiotics, Inc., is incorporated
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX